VEGF-A-induced chemotaxis of CD16+ monocytes is decreased secondary to lower VEGFR-1 expression

Atherosclerosis

Volumn 215, Issue 2, 2011, Pages 331-338

  Czepluch, Frauke S ^a   Olieslagers, Servé ^a   van Hulten, Ruud ^a   Vöö, Stefan A ^a   Waltenberger, Johannes ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Antioxidant enzyme; CD16; Migration; Monocyte; PlGF 1; VEGF A; VEGFR 1

Indexed keywords

CD16 ANTIGEN; MANGANESE SUPEROXIDE DISMUTASE; PLACENTAL GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ARTICLE; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CHEMOKINESIS; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD14; CELL ADHESION; CHEMOTAXIS, LEUKOCYTE; HUMANS; MONOCYTES; REACTIVE OXYGEN SPECIES; RECEPTORS, IGG; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 79953049019     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.01.004     Document Type: Article

References (27)

1. Arras M., Ito W.D., Scholz D., et al. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 1998, 101:40-50.
2. Hansson G.K., Inflammation atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
3. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005, 5:953-964.
4. Passlick B., Flieger D., Ziegler-Heitbrock H.W. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989, 74:2527-2534.
5. Tacke F., Randolph G.J. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 2006, 211:609-618.
6. Sunderkotter C., Nikolic T., Dillon M.J., et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 2004, 172:4410-4417.
7. Fingerle G., Pforte A., Passlick B., et al. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 1993, 82:3170-3176.
8. Schlitt A., Heine G.H., Blankenberg S., et al. CD14+ CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost 2004, 92:419-424.
9. Baeten D., Boots A.M., Steenbakkers P.G., et al. Human cartilage gp-39+,CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum 2000, 43:1233-1243.
10. Heine G.H., Ulrich C., Seibert E., et al. CD14(++)CD16(+) monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int 2008, 73:622-629.
11. Saleh M.N., Goldman S.J., LoBuglio A.F., et al. CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor. Blood 1995, 85:2910-2917.
12. Weber C., Belge K.U., von Hundelshausen P., et al. Differential chemokine receptor expression and function in human monocyte subpopulations. J Leukoc Biol 2000, 67:699-704.
13. Clauss M., Weich H., Breier G., et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 1996, 271:17629-17634.
14. Imhof B.A., Aurrand-Lions M. Adhesion mechanisms regulating the migration of monocytes. Nat Rev Immunol 2004, 4:432-444.
15. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
16. Mobley J.L., Leininger M., Madore S., et al. Genetic evidence of a functional monocyte dichotomy. Inflammation 2007, 30:189-197.
17. Nahrendorf M., Swirski F.K., Aikawa E., et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007, 204:3037-3047.
18. Urra X., Villamor N., Amaro S., et al. Monocyte subtypes predict clinical course and prognosis in human stroke. J Cereb Blood Flow Metab 2009, 29:994-1002.
19. Tsujioka H., Imanishi T., Ikejima H., et al. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol 2009, 54:130-138.
20. Ancuta P., Moses A., Gabuzda D. Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions. Immunobiology 2004, 209:11-20.
21. Fialkow L., Wang Y., Downey G.P. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med 2007, 42:153-164.
22. Mates J.M., Sanchez-Jimenez F. Antioxidant enzymes and their implications in pathophysiologic processes. Front Biosci 1999, 4:D339-345.
23. Dernbach E., Urbich C., Brandes R.P., et al. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 2004, 104:3591-3597.
24. Zhao C., Zhang H., Wong W.C., et al. Identification of novel functional differences in monocyte subsets using proteomic and transcriptomic methods. J Proteome Res 2009, 8:4028-4038.
25. Szaflarska A., Baj-Krzyworzeka M., Siedlar M., et al. Antitumor response of CD14+/CD16+ monocyte subpopulation. Exp Hematol 2004, 32:748-755.
26. Giordano F.J. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005, 115:500-508.
27. Lyons P.A., Koukoulaki M., Hatton A., et al. Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification. BMC Genomics 2007, 8:64.